Big pharma holds steady on research spending

Big pharma holds steady on research spending

Source: 
EP Vantage
snippet: 

Record amounts of money were thrown at drug development in 2021, but last year was a different story. Growth in R&D spending at the world’s 11 largest drugmakers flatlined last year as the urgency to develop Covid products abated, with only two companies – Astrazeneca and Sanofi – showing any real uptick in investment.